MedPath

Movement analysis of individuals with knee arthosis submitted to treatment with intra-articular viscosupplementatio

Phase 1
Recruiting
Conditions
Gonarthrosis
Human Gait
Registration Number
RBR-3n52h4
Lead Sponsor
Instituto Brasil de Tecnologias da Saúde
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Patients registered in the surgery waiting queue; older than 60 yo; able to walk ten meters independently; without external aid.

Exclusion Criteria

valgus or varus deformity higher than fifteen degrees; neurological impairment; indication for bilateral TKA; OA related to periarticular fracture or of septic origin; who have functional limitations in ankle or ipsilateral hip as a result of prior trauma; who do not agree with the consent terms to the research; who refuse to receive the articular infiltrations or perform biomechanical tests; who have no autonomy to raise, sit and/or walk without assistance from other people; illiterate individuals or those who are unable to answer independently the IKDC and LEFS questionnaires; who have used in the last six months or at any time during the study period corticosteroid drugs or surgery in the affected limb.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Expected outcome 1: Improvement in peak angulation of the knee in the sagittal plane during gait support phase after 12 weeks of intervention, verified by the application of statistical tests (linear mixed longitudinal models).;Expected outcome 2: Improvement in peak angulation of the knee in the frontal plane during gait support phase after 12 weeks of intervention, verified by the application of statistical tests (linear mixed longitudinal models).;Expected outcome 3: Improvement in peak angulation of the knee in the transverse plane during gait support phase after 12 weeks of intervention, verified by the application of statistical tests (linear mixed longitudinal models).
Secondary Outcome Measures
NameTimeMethod
Expected outcome 1: Improvement of pain magnitude after 12 weeks of intervention, verified by improvement of at least 2 points on the analog pain scale applied.;Expected outcome 2: Improvement of knee function after 12 weeks of intervention, verified by improvement of at least 8 points in the IKDC evaluation questionnaire.
© Copyright 2025. All Rights Reserved by MedPath